Brewin Dolphin LTD Sanofi Transaction History

Brewin Dolphin LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Nov 09, 2023	SELL	$45.46 - $50.51 $9,092 - $10,102	-200 Reduced 58.65%	141 $6.97 Million
Q4 2020 Nov 09, 2023	SELL	$45.3 - $51.62 $6,795 - $7,743	-150 Reduced 30.55%	341 $16.6 Million
Q2 2020 Nov 09, 2023	BUY	$42.91 - $52.5 $15,018 - $18,375	350 Added 248.23%	491 $25.1 Million
Q1 2018 Nov 09, 2023	SELL	$38.98 - $45.76 $1,208 - $1,418	-31 Reduced 18.02%	141 $5.65 Million
Q3 2017 Nov 09, 2023	BUY	$47.04 - $50.34 $8,090 - $8,658	172	172 $8.56 Million

800

266M

1.82M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $137B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.